{"id":211311,"date":"2017-02-25T17:55:00","date_gmt":"2017-02-25T22:55:00","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/vision-2017-cancer-heart-programs-coming-to-windber-hospital-tribdem-com.php"},"modified":"2017-02-25T17:55:00","modified_gmt":"2017-02-25T22:55:00","slug":"vision-2017-cancer-heart-programs-coming-to-windber-hospital-tribdem-com","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/molecular-medicine\/vision-2017-cancer-heart-programs-coming-to-windber-hospital-tribdem-com.php","title":{"rendered":"Vision 2017 | Cancer, heart programs coming to Windber hospital &#8211; TribDem.com"},"content":{"rendered":"<p><p>    WINDBER  National publicity and    behind-the-scenes upgrades marked the Windber hospital and    research institutes first year under new ownership.  <\/p>\n<p>    More visible developments will come this year as Chan    Soon-Shiong Medical Center at Windber and Chan Soon-Shiong    Institute of Molecular Medicine expand roles in their parent    companys fight against cancer, said Tom Kurtz, president and    CEO of both Windber organizations.  <\/p>\n<p>    New cancer and heart programs are poised for launch at the    Windber hospital, and an expanded tissue repository is already    bringing additionalcancer studies to the research    institute, Kurtz said.  <\/p>\n<p>    Meanwhile, in-patient volumes are up 40    percent over the past seven months, led by a 110 percent    increase in orthopedic surgery, Kurtz said.  <\/p>\n<p>    We are looking at what is needed in the community in    subspecialties, Kurtz said.  <\/p>\n<p>    We are trying to figure out what people are having to travel    out of the community for, and not just keep replicating    everything here.  <\/p>\n<p>    The former Windber Medical Center and Windber Research    Institute began2016 with the news that the two nonprofits    were to become part of Dr. Patrick Soon-Shiongs Chan    Soon-Shiong NantHealth Foundation.  <\/p>\n<p>    On Jan. 11, 2016, the Windber icons were in    the national spotlight when Soon-Shiong announced Cancer    MoonShot 2020, predicting that the joint effort of    international pharmaceutical, bioscience and insurance    companies, working with community-based oncologists, can shave    decades off the development of effective cancer-fighting    drugs.  <\/p>\n<p>    The Windber research institute is now the    central biorepository for tissue and blood samples being    studied by scientistsfrom across the nation, and the    Windber hospital will be joining national cancer drug trials    and demonstrating the valueof bringing the programs to    community hospitals.  <\/p>\n<p>    Last month, Cancer MoonShot 2020 was renamed Cancer    Breakthroughs 2020. The change better reflects progress,    Soon-Shiong said.  <\/p>\n<p>    It will also help end confusion with two other    cancer moon shots: The University of Texas MD Anderson Cancer    Centers Cancer Moon Shots and the national Cancer Moonshot    that was also launched in January 2016 and was headed by    then-Vice President Joe Biden.  <\/p>\n<p>    Windbers cancer treatment center was to open in 2016, but has    been delayed to assure a quality program, Kurtz said.  <\/p>\n<p>    Leaders are still negotiating with larger clinical partners to    help coordinate and oversee treatment and clinical trials, he    said.  <\/p>\n<p>    As part of the nationally renowned Soon-Shiong group, Windber    has many options including many of the nations most-respected    cancer programs.  <\/p>\n<p>    We have a lot of different options, Kurtz said.  <\/p>\n<p>    We want to make sure that what we do with that cancer program    is right for the community.  <\/p>\n<p>    The cancer program will open later this year, Kurtz said,    adding that minimal renovations will be required to put medical    oncology in either the Joyce Murtha Breast Care Center building    or in the former obstetrics unit of the main hospital.  <\/p>\n<p>    The new heart program is expected to begin in    April, led by longtime Johnstown cardiologist Dr. Samir    Hadeed.  <\/p>\n<p>    Hadeed, along with Dr. Cyril Nathaniel and cardiologists of    Central Pennsylvania Physicians Group in Everett, will offer a    full range of cardiology and vascular services.  <\/p>\n<p>    A cardiac catheterization lab is being developed in part of the    former obstetrics unit and has already been approved by the    state Health Department, Hadeed said.  <\/p>\n<p>    Although Hadeed left Conemaugh Health Systems    staff in 2013, he continued his local practice at Johnstown    Heart and Vascular Center at 1027 Broad St. in Johns-  <\/p>\n<p>    town.  <\/p>\n<p>    He has remained active at Windber and Somerset    hospitals and Allegheny Health Network hospitals near    Pittsburgh.  <\/p>\n<p>    I have never been out of the game, he said.  <\/p>\n<p>    Windbers new program brings value to the region, Hadeed said.  <\/p>\n<p>    It gives the community options, he said  <\/p>\n<p>    Having only one program in town is not necessarily the best    for the patient or the town.  <\/p>\n<p>    Both the heart program and the cancer program illustrate the    value of Windbers partnership with Soon-Shiong and his    network, Kurtz said.  <\/p>\n<p>    But all decisions about local patient care and services are    still being made in Windber, he added.  <\/p>\n<p>    They are committed to providing some financial assistance with    the cath lab and to help us with the establishment of the    cancer center here, Kurtz said. Everything else is under our    control.  <\/p>\n<p>    Windber leaders originally decided to seek a national partner    to help the hospital get back on its feet financially.  <\/p>\n<p>    When Windbers board turned over the reins to NantHealth, the    hospital was losing about $2.3 million a year.  <\/p>\n<p>    Kurtz stressed that the local organization does not want to be    a drain on Soon-Shiongs network.  <\/p>\n<p>    As we made an internal decision here, Kurtz    said, any kind of financial assistance made by the national    organization would have a return on investment.  <\/p>\n<p>    We have an internal goal to be totally self-sufficient in 36    months.  <\/p>\n<p>    Along with oncology and cardiology, an upgraded and expanded    emergency department remains a top priority. Kurtz said    previous designs have been put in the back burner while    leadership studies overall needs in light of the new programs    and expanded surgical business.  <\/p>\n<p>    We have to have a campus-wide master facility plan in place,    Kurtz said.  <\/p>\n<p>    Randy Griffith covers health care for The    Tribune-Democrat. Follow him on Twitter    @photogriffer57.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Read the original here: <\/p>\n<p><a target=\"_blank\" href=\"http:\/\/www.tribdem.com\/news\/vision-cancer-heart-programs-coming-to-windber-hospital\/article_44538e84-fa04-11e6-a6a8-f3465c1d3f85.html\" title=\"Vision 2017 | Cancer, heart programs coming to Windber hospital - TribDem.com\">Vision 2017 | Cancer, heart programs coming to Windber hospital - TribDem.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> WINDBER National publicity and behind-the-scenes upgrades marked the Windber hospital and research institutes first year under new ownership. More visible developments will come this year as Chan Soon-Shiong Medical Center at Windber and Chan Soon-Shiong Institute of Molecular Medicine expand roles in their parent companys fight against cancer, said Tom Kurtz, president and CEO of both Windber organizations. New cancer and heart programs are poised for launch at the Windber hospital, and an expanded tissue repository is already bringing additionalcancer studies to the research institute, Kurtz said.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/molecular-medicine\/vision-2017-cancer-heart-programs-coming-to-windber-hospital-tribdem-com.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[26],"tags":[],"class_list":["post-211311","post","type-post","status-publish","format-standard","hentry","category-molecular-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/211311"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=211311"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/211311\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=211311"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=211311"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=211311"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}